From the Journals

Mediastinitis Carries Highest Death Risk Postsurgery

Mediastinitis leads to the highest risk of death within 90 days after surgery.

1

Severe chest bone infections, especially mediastinitis, were significantly associated with increased mortality within 90 days in patients who underwent cardiac surgery.
2

Deep incisional surgical-site infections also posed an elevated mortality risk.
3

Both mediastinitis and deep incisional surgical-site infections should be monitored separately for improved patient survival.
4

Mediastinitis typically developed 14 days postsurgery and was associated with distinct pathogens and outcomes compared to diSSI.
5

Closer monitoring and prompt, aggressive treatment of both infection types may improve survival in patients undergoing cardiac surgery.
6

Risk factors for 90-day mortality included age over 56 years, insulin-dependent diabetes, peripheral arterial disease, prior cardiac surgery, emergency procedures, end-stage renal disease, reduced ejection fraction, and longer cardiopulmonary bypass duration.
7

Study author recommended closer monitoring and aggressive treatment for both infection types to improve survival in patients undergoing cardiac surgery.

1

Severe chest bone infections, especially mediastinitis, were significantly associated with increased mortality within 90 days in patients who underwent cardiac surgery.
2

Deep incisional surgical-site infections also posed an elevated mortality risk.
3

Both mediastinitis and deep incisional surgical-site infections should be monitored separately for improved patient survival.
4

Mediastinitis typically developed 14 days postsurgery and was associated with distinct pathogens and outcomes compared to diSSI.
5

Closer monitoring and prompt, aggressive treatment of both infection types may improve survival in patients undergoing cardiac surgery.
6

Risk factors for 90-day mortality included age over 56 years, insulin-dependent diabetes, peripheral arterial disease, prior cardiac surgery, emergency procedures, end-stage renal disease, reduced ejection fraction, and longer cardiopulmonary bypass duration.
7

Study author recommended closer monitoring and aggressive treatment for both infection types to improve survival in patients undergoing cardiac surgery.

1